News & Views

Read the latest from Baszucki Group and its partners.

Baszucki Brain Research Fund and Milken Institute launch Metabolic Mind Award Program for advancements in metabolic psychiatry

August 17, 2022 — The Baszucki Brain Research Fund and the Milken Institute’s Center for Strategic Philanthropy today announced the launch of the Metabolic Mind Award Program, recognizing champions working at the intersection of metabolism and mental health in the emerging field of metabolic psychiatry. This year’s award focus will be on Ketogenic Metabolic Therapy for mental health.

Read More

A Startup Philanthropy Targeting Serious Mental Illness Ramps Up

July 21, 2022 — The Baszuckis are showing how philanthropy, even one organization, can potentially make a big impact on an underfunded field of research. But they can’t solve this on their own — by getting this new research rolling, their most significant role could be producing promising results that attract new funders to the space.

Read More

Baszucki Brain Research Fund Backs First Clinical Pilot Trials of Ketogenic Metabolic Interventions for Mental Health Conditions in Nearly 60 Years

July 18, 2022 — The Baszucki Brain Research Fund is pleased to announce that five science teams around the globe have received funding to study ketogenic metabolic interventions for bipolar disorder, schizophrenia and major depressive disorder.

Read More

A New Therapy with Magnets is Helping People with Depression when Nothing Else Works

July 7, 2022 — This 5-minute NBC segment showcases another promising area the Baszuckis have invested in: a more targeted approach to Transcranial Magnetic Stimulation (TMS), facilitated by Magnus Medical. The company was able to end their FDA study early because the results were so impactful — 80% of depressed patients went into remission.

Read More